Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
VE800 is a mixture comprised of 11 clonally-derived human commensal bacterial strains, which potentially enhances anti-tumor immune responses leading to reduced tumor growth (PMID: 30675064).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Nivolumab + Vancomycin + VE800||Nivolumab VE800 Vancomycin||0||1|
|unspecified CTLA4 antibody + VE800||VE800 unspecified CTLA4 antibody||1||0|
|unspecified PD-1 antibody + VE800||VE800 unspecified PD-1 antibody||1||0|